Global H1N1 Vaccines Market Size, Share, Analysis, Trends, Growth, 2032

H1N1 Vaccines Market

H1N1 Vaccines Market - By Route Of Administration (Intradermal Vaccines, Intranasal Vaccines, and Intramuscular Vaccines), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2976 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 3.79 Billion USD 5.90 Billion 4.5% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. H1N1 Vaccines Market, 2015–2025 (USD Billion)
    • 2.2. H1N1 Vaccines Market: Snapshot
  • Chapter 3. Global H1N1 Vaccines Market– Industry Analysis
    • 3.1. H1N1 Vaccines Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. With large number of vaccine producers emerging in countries such as India, China, and Thailand as well as countries of South America, the H1N1 vaccines industry is anticipated to witness accelerated growth in the coming decade.
      • 3.2.2. Growing awareness among the patients about preventing swine flu and technulogical breakthroughs in the healthcare sector is projected to pave a way for the market growth over the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Route of Administration
  • Chapter 4. Global H1N1 Vaccines Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global H1N1 Vaccines Market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global H1N1 Vaccines Market– Route of Administration Analysis
    • 5.1. Global H1N1 Vaccines Market overview: By Route of Administration
      • 5.1.1. Global H1N1 Vaccines Market share, By Route of Administration, 2018 and 2025
    • 5.2. Intradermal Vaccines
      • 5.2.1. Global H1N1 Vaccines Market By Intradermal Vaccines, 2015–2025 (USD Billion)
    • 5.3. Intranasal Vaccines
      • 5.3.1. Global H1N1 Vaccines Market By Intranasal Vaccines, 2015–2025 (USD Billion)
    • 5.4. Intramuscular Vaccines
      • 5.4.1. Global H1N1 Vaccines Market By Intramuscular Vaccines, 2015–2025 (USD Billion)
  • Chapter 6. Company Profiles
    • 6.1. GlaxoSmithKline
      • 6.1.1. Overview
      • 6.1.2. Financials
      • 6.1.3. Product Portfolio
      • 6.1.4. Business Strategy
      • 6.1.5. Recent Developments
    • 6.2. Medimmune
      • 6.2.1. Overview
      • 6.2.2. Financials
      • 6.2.3. Product Portfolio
      • 6.2.4. Business Strategy
      • 6.2.5. Recent Developments
    • 6.3. Novartis
      • 6.3.1. Overview
      • 6.3.2. Financials
      • 6.3.3. Product Portfolio
      • 6.3.4. Business Strategy
      • 6.3.5. Recent Developments
    • 6.4. AstraZeneca plc
      • 6.4.1. Overview
      • 6.4.2. Financials
      • 6.4.3. Product Portfolio
      • 6.4.4. Business Strategy
      • 6.4.5. Recent Developments
    • 6.5. Sinovac Biotech
      • 6.5.1. Overview
      • 6.5.2. Financials
      • 6.5.3. Product Portfolio
      • 6.5.4. Business Strategy
      • 6.5.5. Recent Development
    • 6.6. Sanofi AG
      • 6.6.1. Overview
      • 6.6.2. Financials
      • 6.6.3. Product Portfolio
      • 6.6.4. Business Strategy
      • 6.6.5. Recent Development
    • 6.7. Commonwealth Serum Laboratories
      • 6.7.1. Overview
      • 6.7.2. Financials
      • 6.7.3. Product Portfolio
      • 6.7.4. Business Strategy
      • 6.7.5. Recent Development
    • 6.8. Baxter
      • 6.8.1. Overview
      • 6.8.2. Financials
      • 6.8.3. Product Portfolio
      • 6.8.4. Business Strategy
      • 6.8.5. Recent Development
    • 6.9. Zydus Cadila
      • 6.9.1. Overview
      • 6.9.2. Financials
      • 6.9.3. Product Portfolio
      • 6.9.4. Business Strategy
      • 6.9.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global H1N1 Vaccines Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global H1N1 Vaccines Market attractiveness, By Route of Administration 
6.  Global H1N1 Vaccines Market Share by Route of Administration ,2018 and 2025 (USD Billion)
7. Global H1N1 Vaccines Market by Intradermal Vaccines ,2015–2025 (USD Billion)
8. Global H1N1 Vaccines Market by Intranasal Vaccines ,2015–2025 (USD Billion)
9. Global H1N1 Vaccines Market by Intramuscular Vaccines,2015–2025 (USD Billion)
10. Global H1N1 Vaccines Market share, by Region, 2018 and 2025
11. North America H1N1 Vaccines Market, 2015–2025 (USD Billion)
12. Europe H1N1 Vaccines Market, 2015–2025 (USD Billion)
13. Asia Pacific H1N1 Vaccines Market, 2015–2025 (USD Billion)
14. Latin America H1N1 Vaccines Market, 2015–2025 (USD Billion)
15. The Middle East and Africa H1N1 Vaccines Market, 2015–2025 (USD Billion)
 


Table Of Tables

List of Tables

1. Global H1N1 Vaccines Market: snapshot
2. Drivers of the H1N1 Vaccines Market: impact analysis
3. North America H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
4. The U.S. H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
5. Rest of North America H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
6. Europe H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
7. UK H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
8. France H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
9. Germany H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
10. Rest of Europe H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
11. Asia Pacific H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
12. China H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
13. Japan H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
14. India H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
15. Rest of Asia Pacific H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
16. Latin America H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
17. Brazil H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
18. Rest of Latin America H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
19. The Middle East and Africa H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
20. Saudi Arabia H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
21. South Africa H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
22. Rest of the Middle East & Africa H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)

 
 

Methodology

FrequentlyAsked Questions

H1N1 vaccines protect against the H1N1 influenza virus. They help prevent infection and reduce disease severity

The global H1N1 Vaccines market is expected to be driven by the recurring influenza outbreaks, government immunization programs, and public health preparedness. Advances in vaccine development support market growth.

According to study, the global H1N1 Vaccines market size was worth around USD 3.79 Billion in 2023 and is predicted to grow to around USD 5.90 Billion By 2032.

The global H1N1 Vaccines market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 4.5% during the forecast period from 2024-2032.

The global H1N1 Vaccines industry is projected to be challenged by Challenges include unpredictable outbreak patterns, production lead times, and vaccine hesitancy.

The Opportunities include pandemic preparedness programs, government stockpiling, improved vaccine platforms, and global immunization initiatives will offer significant growth opportunities in the H1N1 Vaccines market.

Cell-based and recombinant vaccine platforms; faster scale-up and distribution; integration with seasonal flu programs are the emerging trends and innovations impacting the H1N1 Vaccines market.

The global H1N1 Vaccines market is expected to be led by North America during the forecast period.

Some of the prominent players operating in the global H1N1 Vaccines market are; Baxter, Commonwealth Serum Laboratories, GlaxoSmithKline, Sanofi AG., Medimmune, AstraZeneca plc, Sinovac Biotech, Novartis, and Zydus Cadila and others.

The report explores crucial aspects of the H1N1 Vaccines market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

What is the Market size of the H1N1 vaccines market?Market:OverviewMarket:Growth DriversReport ScopeMarket:SegmentationMarket:Regional InsightsMarket:Competitive SpaceThe global H1N1 vaccines market is segmented as follows:

HappyClients